BioDelivery Sciences (BDSI) Misses Q2 EPS by 6c

BioDelivery Sciences (NASDAQ: BDSI) reported Q2 EPS of ($0.37), $0.06 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $3.29 million.

For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c